Monday, October 02, 2017 7:16:49 PM
If you wish submit your guess (or update your guess) please do it till December 31, 2017.
(Please, do not guess a Sat or Sun or a US Holiday ... )
- onset (start of the process, was March 31, 2016 @ 1st and March 16, 2017 @ 2nd) - mmm.dd (d1)
- top line result announcement (was (DMC rec.) September 12, 2016 @ 1st and August 14, 2017 @ 2nd) - mmm.dd (d2)
- Eff% - xx.xx% (r)
Rules (if you have different proposal, please advise):
* weight:
- onset - 30% (w1)
- announcement (top line result) - 30% (w2)
- Eff% - 40% (w3)
* difference:
- D1: ABS (real date of onset - d1)
- D2: ABS (real date of announcement - d2)
* D3: (ABS (RRR - r)) - difference of r (and RRR) in percentage 2 digits, eg. 1.15% diff = 115 score
* D1 x w1 + D2 x w2 + D3 x w3 = score
* lowest score will win
"Sub-rules" (if you have different proposal, please advise):
- no data = the highest score in the category + 10%
Please note: (more likely) top line result won't include Eff. % data, it will be announced later.
...............................................................................................................................................................................
Babr: Feb. 01. / Apr. 27. / 24,00%
golf stud: Feb. 05. / Jul. 16. / 37,00%
VuBru: Feb. 07. / Jun. 05. / 19,00%
FishyFingers: Feb. 08. / Jun. 20. / 35,00%
GD: Feb. 13. / May. 21. / 29,50%
Chris2125: Feb. 14. / Jun. 11. / 30,00%
rafunrafun: Feb. 15. / Jun. 25. / 33,00%
HDGabor: Feb. 15. / Jul. 09. / 36,00%
ziploc_1: Feb. 15. / Jul. 16. / 40,00%
Whalatane: Feb. 16. / Jun. 18. / 14,00%
mrmainstreet: Feb. 19. / Sep. 24. / 18,00%
Krishkris: Feb. 20. / Jul. 30. / 26,00%
marzan: Feb. 23. / Aug. 17. / 53,00%
KevGee59: Feb. 26. / Jul. 23. / 19,00%
Albino2: Mar. 01. / Jul. 23. / 39,00%
rydad21: Mar. 05. / Jul. 09. / 24,00%
tasgrewaf: Mar. 09. / Aug. 10. / 23,45%
shadolane: Mar. 12. / Jul. 23. / 21,00%
ibew 488: Mar. 14. / Jul. 27. / 31,00%
staccani: Mar. 15. / Jun. 15. / 25,00%
CaptBeer: Mar. 15. / Jul. 03. / 35,00%
Hondo1021: Mar. 15. / Jul. 13. / 28,00%
silver-dollar-17: Mar. 15. / Aug. 15. / 30,00%
jessellivermore: Mar. 19. / Jul. 16. / 33,00%
bfost: Mar. 26. / Jul. 23. / 20,00%
Flounderguy: Mar. 26. / Aug. 06. / 37,00%
louieblouie: Mar. 28. / Aug. 08. / 22,00%
Invest83838: Apr. 12. / Aug. 13. / 32,00%
Tatsumaki: Apr. 19. / Aug. 30. / 30,20%
...............................................................................................................................................................................
Best,
G
#NEWMIAMI
Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.
Do Your Job
Recent AMRN News
- Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual Europe • GlobeNewswire Inc. • 09/09/2024 11:30:00 AM
- Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress • GlobeNewswire Inc. • 08/22/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 09:30:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:54:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:54:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 11:05:34 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 11:05:26 AM
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 07/31/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 09:30:08 PM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal • GlobeNewswire Inc. • 07/17/2024 08:15:00 PM
- Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024 • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR) • GlobeNewswire Inc. • 07/08/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM